UNSPSC 51293803: Modaline sulfate

This classification denotes an antidepressant agent with the molecular formula C10H15N3.H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NH3315AI6E, chemically known as pyrazine, 2-methyl-3-piperidino-, sulfate but more generally known as modaline sulfate, which bears US NIH Compound Identifier 17859. Most nations, for tariff and trade purposes, schedule modaline sulfate under HS 29333999 and SITC 51574. As of Q4 2014, MODALINE SULFATE remains US FDA's Preferred Term for this commodity.

Modaline sulfate bears US NLM identifiers UMLS ID C2983847 and NCI Concept Code C90711. SMILES: CC1C(NCCN1)N2CCCCC2.OS(=O)(=O)O.

UNSPSC 51293803 Modaline sulfate, a Commodity-tier code, nominally addresses a specific pharmaceutical compound, but recent state and local solicitations tagged under this code show no direct procurement activity for modaline sulfate itself. Instead, the tagged opportunities reflect broader pharmaceutical and drug-response procurement — naloxone acquisition, direct-to-manufacturer prescription programs, and generic multi-source pharmaceutical contracts. The mismatch between the code's nominal scope and actual buying activity suggests that state and local procurement offices are using this code imprecisely or that modaline sulfate procurement, if it occurs, is not being actively solicited in the current environment. State and local issuing bodies represented in the recent-opportunities block include a Florida county health authority (Seminole County), a state health agency (Texas HHS Commission), and a multistate cooperative purchasing alliance (Minnesota MMCAP). The purchasing mix reflects institutional health care and public health supply chains serving county community health departments and state pharmacy benefit programs.

Recent activity appears concentrated in the South and Upper Midwest. Seminole County, Florida issued an Invitation for Bid (IFB 60459723LAS) in June 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building, due July 26, 2023 (note: an apparent date error in the source). Texas HHS Commission issued a Request for Information (RFI HHS0017013) in April 2026 to assess vendor capabilities for direct-to-manufacturer prescription programs outside of traditional pharmacy benefit manager channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued a Request for Proposal (RFP S1070000015802) in January 2026 for generic multi-source pharmaceuticals and OTC products serving participating state and local government facilities across multiple jurisdictions, including Oregon, with a response deadline of March 26, 2026. No recent opportunities directly reference modaline sulfate procurement, and state and local buyers pursuing pharmaceutical supply under this code appear focused on high-volume products (naloxone, generics) and program-level partnerships rather than specialty compounds.